B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income -18.48% -25.78% -28.13% -28.64% 51.73%
Total Depreciation and Amortization 57.21% 40.47% 24.25% 8.29% 0.24%
Total Amortization of Deferred Charges 17.14% 12.52% 7.32% 2.12% 0.90%
Total Other Non-Cash Items 795.07% 2,791.17% 1,130.52% 999.72% -29.74%
Change in Net Operating Assets 1.05% -21.53% -79.88% -70.54% 16.54%
Cash from Operations 47.02% 49.44% 34.45% 36.01% 51.63%
Capital Expenditure -44.17% -74.68% -20.49% 34.84% 16.06%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -120.82% 196.60% 205.48% 174.25% 180.64%
Cash from Investing -448.80% -321.70% -69.44% -107.75% 175.03%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 49.56% 9.18% -30.98% -30.98% -30.09%
Repurchase of Common Stock 32.47% 32.86% -34.48% -36.68% -134.33%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 187.43% 79.11% 62.35% 61.08% -156.83%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 130.33% 181.05% 1,059.57% 916.31% 321.29%